IDEX Operating Cash Flow decreased by 50.5% to $103.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.9%, from $105.70M to $103.70M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 4.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $136.30M | $156.60M | $163.10M | $79.70M | $112.30M | $198.10M | $167.30M | $147.90M | $141.20M | $226.60M | $201.00M | $156.60M | $133.60M | $205.30M | $172.60M | $105.70M | $161.70M | $203.50M | $209.50M | $103.70M |
| QoQ Change | — | +14.9% | +4.2% | -51.1% | +40.9% | +76.4% | -15.5% | -11.6% | -4.5% | +60.5% | -11.3% | -22.1% | -14.7% | +53.7% | -15.9% | -38.8% | +53.0% | +25.9% | +2.9% | -50.5% |
| YoY Change | — | — | — | — | -17.6% | +26.5% | +2.6% | +85.6% | +25.7% | +14.4% | +20.1% | +5.9% | -5.4% | -9.4% | -14.1% | -32.5% | +21.0% | -0.9% | +21.4% | -1.9% |